Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jude Fitzgibbon

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
American Journal of Human Genetics|June 28, 2016
DNAJC21 Mutations Link a Cancer-Prone Bone Marrow Failure Syndrome to Corruption in 60S Ribosome Subunit MaturationHemanth Tummala, Amanda J Walne, Mike Williams, et al.
British Journal of Haematology|February 6, 2023
Germline predisposition to haematological malignancies: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar and the NHS England Haematological Oncology Working GroupBeverley Speight, Helen Hanson, Clare Turnbull, et al.
British Journal of Haematology|September 26, 2022
Germline ERCC excision repair 6 like 2 (ERCC6L2) mutations lead to impaired erythropoiesis and reshaping of the bone marrow microenvironmentHannah Armes, Findlay Bewicke-Copley, Ana Rio-Machin, et al.
Signal Transduction and Targeted Therapy|February 27, 2023
Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypesPedro Casado, Ana Rio-Machin, Juho J Miettinen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 9, 2024
Profiling of Copy Number Alterations Using Low-Coverage Whole-Genome Sequencing Informs Differential Diagnosis and Prognosis in Primary Cutaneous Follicle Center LymphomaBence Bátai, Laura Kiss, Luca Varga, et al.
Science Advances|July 17, 2019
Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AMLJanus S Jakobsen, Linea G Laursen, Mikkel B Schuster, et al.
The Journal of Experimental Medicine|September 5, 2024
SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphomaAna Portelinha, Shenqiu Wang, Sara Parsa, et al.
British Journal of Haematology|August 27, 2024
CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphomaEmil Arjun Kumar, Koorosh Korfi, Findlay Bewicke-Copley, et al.
Leukemia|March 24, 2019
Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphomaShamzah Araf, Jun Wang, Koorosh Korfi, et al.
European Journal of Medical Genetics|February 12, 2023
European standard clinical practice - Key issues for the medical care of individuals with familial leukemiaAlisa Förster, Claudia Davenport, Nicolas Duployez, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
American Journal of Human Genetics|June 28, 2016
DNAJC21 Mutations Link a Cancer-Prone Bone Marrow Failure Syndrome to Corruption in 60S Ribosome Subunit MaturationHemanth Tummala, Amanda J Walne, Mike Williams, et al.
British Journal of Haematology|February 6, 2023
Germline predisposition to haematological malignancies: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar and the NHS England Haematological Oncology Working GroupBeverley Speight, Helen Hanson, Clare Turnbull, et al.
British Journal of Haematology|September 26, 2022
Germline ERCC excision repair 6 like 2 (ERCC6L2) mutations lead to impaired erythropoiesis and reshaping of the bone marrow microenvironmentHannah Armes, Findlay Bewicke-Copley, Ana Rio-Machin, et al.
Signal Transduction and Targeted Therapy|February 27, 2023
Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypesPedro Casado, Ana Rio-Machin, Juho J Miettinen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 9, 2024
Profiling of Copy Number Alterations Using Low-Coverage Whole-Genome Sequencing Informs Differential Diagnosis and Prognosis in Primary Cutaneous Follicle Center LymphomaBence Bátai, Laura Kiss, Luca Varga, et al.
Science Advances|July 17, 2019
Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AMLJanus S Jakobsen, Linea G Laursen, Mikkel B Schuster, et al.
The Journal of Experimental Medicine|September 5, 2024
SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphomaAna Portelinha, Shenqiu Wang, Sara Parsa, et al.
British Journal of Haematology|August 27, 2024
CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphomaEmil Arjun Kumar, Koorosh Korfi, Findlay Bewicke-Copley, et al.
Leukemia|March 24, 2019
Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphomaShamzah Araf, Jun Wang, Koorosh Korfi, et al.
European Journal of Medical Genetics|February 12, 2023
European standard clinical practice - Key issues for the medical care of individuals with familial leukemiaAlisa Förster, Claudia Davenport, Nicolas Duployez, et al.
Pageof 9